Identification of a forskolin-like molecule in human renal cysts

被引:44
作者
Putnam, William C.
Swenson, Sarah M.
Reif, Gail A.
Wallace, Darren P.
Helmkamp, George M., Jr.
Grantham, Jared J.
机构
[1] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66160 USA
[2] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA
[3] Midwest Res Inst, Kansas City, MO 64110 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2007年 / 18卷 / 03期
关键词
D O I
10.1681/ASN.2006111218
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal cyst enlargement is increased by adenosine cAMP, which is produced within mural epithelial cells. In a search for modulators of cAMP synthesis cyst fluids from 18 patients with autosomal dominant or recessive polycystic kidney disease (PKD) were analyzed, and in 15 of them, a stable lipophilic molecule that increased cAMP levels, stimulated transepithelial chloride and fluid secretion, and promoted the proliferation of human cyst epithelial cells was characterized. With the use of HPLC-mass spectrometry, a bioactive lipid with the same mass spectral fingerprint, the same chromatographic retention time, and the same biologic properties as forskolin, a widely known, potent adenylyl cyclase agonist, has been isolated and identified within the cyst fluid. Forskolin is synthesized by the plant Coleus forskohlii, but its appearance or compounds like it have not been reported in animals. The origin of forskolin in patients with PKD was not revealed by this study. Synthesis by mural cyst epithelial cells or an exogenous source are the most likely possibilities. Forskolin is sold for weight management and as a cardiovascular tonic in health stores and through the Worldwide Web. It is concluded that forskolin may have a role in promoting the enlargement of cysts in autosomal dominant PKD and recommended that patients avoid oral and parenteral preparations that contain this compound.
引用
收藏
页码:934 / 943
页数:10
相关论文
共 28 条
[1]   Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells [J].
Belibi, FA ;
Reif, G ;
Wallace, DP ;
Yamaguchi, T ;
Olsen, L ;
Li, H ;
Helmkamp, GM ;
Grantham, JJ .
KIDNEY INTERNATIONAL, 2004, 66 (03) :964-973
[2]   Molecular cloning and functional expression of geranylgeranyl pyrophosphate synthase from Coleus forskohlii Briq [J].
Engprasert S. ;
Taura F. ;
Kawamukai M. ;
Shoyama Y. .
BMC Plant Biology, 4 (1)
[3]  
ERICSSON J, 1993, J BIOL CHEM, V268, P832
[4]  
Gattone VH, 1999, DEV GENET, V24, P309, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<309::AID-DVG14>3.0.CO
[5]  
2-5
[6]   Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist [J].
Gattone, VH ;
Wang, XF ;
Harris, PC ;
Torres, VE .
NATURE MEDICINE, 2003, 9 (10) :1323-1326
[7]   Volume progression in autosomal dominant polycystic kidney disease: The major factor determining clinical outcomes [J].
Grantham, Jared J. ;
Chapman, Arlene B. ;
Torres, Vicente E. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (01) :148-157
[8]   IN-VITRO FLUID SECRETION BY EPITHELIUM FROM POLYCYSTIC KIDNEYS [J].
GRANTHAM, JJ ;
YE, M ;
GATTONE, VH ;
SULLIVAN, LP .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01) :195-202
[9]  
Grantham JJ, 1997, P ASSOC AM PHYSICIAN, V109, P397
[10]  
GRANTHAM JJ, 1995, J AM SOC NEPHROL, V6, P1242